Atrium Therapeutics, Inc. Material Contracts
Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.
- 2026-02-27: Form 8-K; Exhibit 10.4; Description Employment Agreement, dated as of February 26, 2026, by and between Atrium Therapeutics, Inc. and Brendan Winslow#.
- 2026-02-27: Form 8-K; Exhibit 10.3; Description Employment Agreement, dated as of February 26, 2026, by and between Atrium Therapeutics, Inc. and Kathleen Gallagher#.
- 2026-02-27: Form 8-K; Exhibit 10.2; Description Transition Services Agreement, dated as of February 26, 2026, by and between Avidity Biosciences, Inc. and Atrium Therapeutics, Inc.*.
- 2026-02-27: Form 8-K; Exhibit 10.1; Description Amended and Restated License Agreement, dated as of February 26, 2026, by and between Avidity Biosciences, Inc. and Atrium Therapeutics, Inc.*.
| Filed | Form | Exhibit | Description |
|---|
| 2026-02-27 | 8-K | 10.4 | Employment Agreement, dated as of February 26, 2026, by and between Atrium Therapeutics, Inc. and Brendan Winslow# |
|---|
| 2026-02-27 | 8-K | 10.3 | Employment Agreement, dated as of February 26, 2026, by and between Atrium Therapeutics, Inc. and Kathleen Gallagher# |
|---|
| 2026-02-27 | 8-K | 10.2 | Transition Services Agreement, dated as of February 26, 2026, by and between Avidity Biosciences, Inc. and Atrium Therapeutics, Inc.* |
|---|
| 2026-02-27 | 8-K | 10.1 | Amended and Restated License Agreement, dated as of February 26, 2026, by and between Avidity Biosciences, Inc. and Atrium Therapeutics, Inc.* |
|---|